Could it be true that smoking cannabis is linked to a higher risk of heart attacks? A new study suggests the possibility of a connection, raising important questions about cardiovascular health and cannabis use. While the findings aren’t conclusive, they point to the need for further research into how cannabis may affect the heart.
A comprehensive global review led by researchers at the University of Toulouse has concluded that cannabis use may double the risk of death from cardiovascular disease, while also raising stroke risk by around 20%—a finding that has sparked fresh concern amid spiraling cannabis popularity worldwide. The study, published in Heart, aggregated data from 24 large-scale observational studies with nearly 200 million participants aged 19–59 across multiple countries, and reveals a 29% increased risk of acute coronary syndrome among users.
Lead authors caution that, although some study limitations remain—such as inconsistent cannabis exposure metrics—this analysis offers the most robust and conclusive look at cannabis-related heart risk to date. The authors emphasized that rising use of high-potency concentrates, vapes, edibles, and synthetic cannabinoids may exacerbate cardiovascular concerns. Notably, they called for regulatory frameworks to incorporate product-level risk management, public health warnings, and marketing restrictions similar to tobacco oversight.
Health professionals in the U.S., including cardiologists at UCSF, echoed the findings. They warn practitioners and dispensaries need to factor cardiovascular risk—especially for users with hypertension, diabetes, or existing heart conditions—into education and harm-reduction programs. Professor Stanton Glantz stressed that policymakers should require clear labeling, potency limits, and public awareness campaigns.
For everyday cannabis consumers—particularly adults who rely on THC for medical or recreational use—these findings underline the importance of caution and awareness. The review does not differentiate between consumption methods, but questions linger about whether inhaled forms pose higher risk than edibles or tinctures. Given the data gaps, experts suggest moderation, medical consultation, and prioritizing low-THC or CBD-rich alternatives to reduce strain on the cardiovascular system.
Cannabis or Smoking…
However, and this may be crucial, follow-up research is needed to determine whether the increased risk is due to cannabis itself or the act of smoking. Since smoking—regardless of substance—is already associated with cardiovascular harm, it’s possible that the method of consumption, rather than cannabis alone, plays a significant role.
Culturally, the study’s release may shift narratives. As cannabis transforms in public perception—from counterculture symbol to legal wellness commodity—this research highlights the need for science-based consumer education. It prompts deeper conversations around safe use patterns, especially in older age groups: seniors with age-related heart risks should approach cannabis more cautiously than younger users.
Regulatory bodies are already taking notice. Canada’s Health Canada and parts of the U.S. have begun updating cannabis labeling guidelines, and U.K. public health agencies are reviewing use penalties for case usage. The Guardian article notes potential policy innovations, including mandatory heart risk disclosures and new limits on THC concentration for at-risk groups.
Source: The Guardian, Research
